Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$4.08 - $5.82 $1.66 Million - $2.37 Million
-406,751 Reduced 30.91%
909,083 $4.96 Million
Q2 2022

Aug 08, 2022

SELL
$4.15 - $8.37 $120,744 - $243,525
-29,095 Reduced 2.16%
1,315,834 $5.93 Million
Q1 2022

May 05, 2022

BUY
$5.91 - $14.38 $403,623 - $982,082
68,295 Added 5.35%
1,344,929 $9.91 Million
Q4 2021

Feb 14, 2022

SELL
$5.21 - $8.61 $652,432 - $1.08 Million
-125,227 Reduced 8.93%
1,276,634 $8.21 Million
Q3 2021

Nov 09, 2021

SELL
$4.45 - $10.63 $33,535 - $80,107
-7,536 Reduced 0.53%
1,401,861 $8.16 Million
Q2 2021

Jul 29, 2021

SELL
$8.11 - $11.11 $1.25 Million - $1.71 Million
-153,647 Reduced 9.83%
1,409,397 $14.5 Million
Q1 2021

May 14, 2021

BUY
$9.85 - $17.69 $103,819 - $186,452
10,540 Added 0.68%
1,563,044 $16.4 Million
Q4 2020

Feb 16, 2021

BUY
$14.15 - $17.19 $1.38 Million - $1.67 Million
97,282 Added 6.69%
1,552,504 $24 Million
Q3 2020

Nov 16, 2020

BUY
$14.14 - $19.71 $9.8 Million - $13.7 Million
693,403 Added 91.02%
1,455,222 $21.2 Million
Q2 2020

Aug 14, 2020

BUY
$16.6 - $25.25 $2.74 Million - $4.17 Million
165,074 Added 27.66%
761,819 $14.4 Million
Q1 2020

May 15, 2020

BUY
$14.38 - $27.72 $8.58 Million - $16.5 Million
596,745 New
596,745 $11.5 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.